Ferric Carboxymaltose for the Correction of Cancer- and Chemotherapy-Assiciated Anemia in Clinical Practice.

Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011.

haematologica 96(s2), 0983.

Studie: Ferinject-NIS; Indikation: Supportivtherapie; Jahr: 2011; Veranstaltung: EHA; Journal: Haematologica

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com